v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Private placement warrants
Common Stock
Common Stock
Private placement warrants
Additional paid-in capital
Additional paid-in capital
Private placement warrants
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024     121,599,488          
Beginning balance at Dec. 31, 2024 $ 287,618   $ 12   $ 388,979   $ 27 $ (101,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (18,200)             (18,200)
Share-based compensation 4,144       4,144      
Issuance of common stock under stock compensation plans (in shares)     535,453          
Issuance of common stock under stock compensation plans 44       44      
Unrealized net gain (loss) on available-for-sale securities (19)           (19)  
ATM facility issuance costs (71)       (71)      
Ending balance (in shares) at Mar. 31, 2025     122,134,941          
Ending balance at Mar. 31, 2025 273,516   $ 12   393,096   8 (119,600)
Beginning balance (in shares) at Dec. 31, 2024     121,599,488          
Beginning balance at Dec. 31, 2024 287,618   $ 12   388,979   27 (101,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (50,600)              
Unrealized net gain (loss) on available-for-sale securities (22)              
Ending balance (in shares) at Sep. 30, 2025     143,955,400          
Ending balance at Sep. 30, 2025 277,444   $ 14   429,425   5 (152,000)
Beginning balance (in shares) at Mar. 31, 2025     122,134,941          
Beginning balance at Mar. 31, 2025 273,516   $ 12   393,096   8 (119,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (15,875)             (15,875)
Share-based compensation 4,111       4,111      
Issuance of common stock under stock compensation plans (in shares)     566,353          
Issuance of common stock under stock compensation plans 297       297      
Unrealized net gain (loss) on available-for-sale securities (10)           (10)  
ATM facility issuance costs 25       25      
Ending balance (in shares) at Jun. 30, 2025     122,701,294          
Ending balance at Jun. 30, 2025 262,064   $ 12   397,529   (2) (135,475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (16,525)             (16,525)
Share-based compensation 3,963       3,963      
Unrealized net gain (loss) on available-for-sale securities 7           7  
Issuance of common stock in private placement, net of commissions and issuance costs (in shares)       21,254,106        
Issuance of common stock in private placement, net of commissions and issuance costs   $ 27,935   $ 2   $ 27,933    
Ending balance (in shares) at Sep. 30, 2025     143,955,400          
Ending balance at Sep. 30, 2025 277,444   $ 14   429,425   5 (152,000)
Beginning balance (in shares) at Dec. 31, 2025     144,308,383          
Beginning balance at Dec. 31, 2025 267,027   $ 14   433,180   12 (166,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (7,707)             (7,707)
Share-based compensation 3,340       3,340      
Issuance of common stock under stock compensation plans (in shares)     475,430          
Unrealized net gain (loss) on available-for-sale securities (14)           (14)  
Ending balance (in shares) at Mar. 31, 2026     144,783,813          
Ending balance at Mar. 31, 2026 262,646   $ 14   436,520   (2) (173,886)
Beginning balance (in shares) at Dec. 31, 2025     144,308,383          
Beginning balance at Dec. 31, 2025 267,027   $ 14   433,180   12 (166,179)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (29,294)              
Unrealized net gain (loss) on available-for-sale securities (84)              
Ending balance (in shares) at Sep. 30, 2026     145,855,652          
Ending balance at Sep. 30, 2026 249,160   $ 15   444,690   (72) (195,473)
Beginning balance (in shares) at Mar. 31, 2026     144,783,813          
Beginning balance at Mar. 31, 2026 262,646   $ 14   436,520   (2) (173,886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (5,859)             (5,859)
Share-based compensation 3,159       3,159      
Issuance of common stock under stock compensation plans (in shares)     606,585          
Issuance of common stock under stock compensation plans 346   $ 1   345      
Unrealized net gain (loss) on available-for-sale securities (18)           (18)  
Ending balance (in shares) at Jun. 30, 2026     145,390,398          
Ending balance at Jun. 30, 2026 260,274   $ 15   440,024   (20) (179,745)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (15,728)             (15,728)
Share-based compensation 3,058       3,058      
Issuance of common stock under stock compensation plans (in shares)     465,254          
Issuance of common stock under stock compensation plans 1,608       1,608      
Unrealized net gain (loss) on available-for-sale securities (52)           (52)  
Ending balance (in shares) at Sep. 30, 2026     145,855,652          
Ending balance at Sep. 30, 2026 $ 249,160   $ 15   $ 444,690   $ (72) $ (195,473)